Salic

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Salic

What is Salic? A Topical Combination Overview

Property Description
Active Ingredients Betamethasone Dipropionate, Sodium Salicylate
Form Topical Preparations (Ointment, Lotion)
Pharmacological Class Topical Corticosteroid and Keratolytic Agent
General Purpose Relieves inflammation and excessive skin scaling
Origin Synthetic

What Type of Medicine is Salic? A Fixed-Dose Combination

Salic is a fixed-dose combination topical medication containing two distinct, synthetic active ingredients for direct application to the skin or scalp. This structure classifies it as a combination of a High-Potency Topical Corticosteroid and a Keratolytic Agent. This dual formulation is utilized in dermatological practice to address conditions that require simultaneous suppression of inflammation and reduction of skin thickening.

The active component, Betamethasone Dipropionate, is a potent fluorinated glucocorticoid designed to suppress inflammatory processes. Pharmacological studies have clinically recognized the efficacy of combining a potent topical steroid with a keratolytic for managing hyperkeratotic skin conditions, supporting its use in formulations like Salic.


Composition and Dual-Action Benefit

The medication is formulated as various topical preparations, typically as an ointment or a lotion, using an emollient or vehicle base to facilitate component delivery. The primary purpose of Salic is to relieve symptoms associated with inflammatory skin conditions that are also characterized by excessive skin thickening.

The resulting dual-action benefit is achieved because the Betamethasone component works as a powerful anti-inflammatory agent, reducing redness and swelling. Concurrently, the Sodium Salicylate component works by softening keratin, which aids in the necessary removal of excessive dead skin cells from the outer layer. This integrated physiological approach targets both the source of the inflammation and the physical barrier presented by the skin thickening.

Regulatory References

  1. Topical Corticosteroids

What side effects are possible with Salic?

Possible Side Effects and Safety Information

The information below summarizes the adverse reactions and safety restrictions for Salic as documented in official government regulatory sources, such as the FDA and EMA. This text does not contain instructions for use, dosing, or therapeutic benefits.

Serious Adverse Reactions and Safety Restrictions

Official documents highlight the risk of Reye's syndrome, a rare but severe illness that can cause brain and liver damage. Consequently, Salic is contraindicated for use in children and teenagers who have or are recovering from chickenpox or flu-like symptoms.

Immediate medical attention is required for signs of a severe allergic reaction (anaphylaxis), which, though rare, is a documented adverse event. Symptoms may include hives, facial swelling, difficulty breathing, or shock.

Common Adverse Reactions and Limitations

Adverse reactions that are frequently reported, particularly with topical use, involve the application site itself. These common local reactions may include minor skin irritation, stinging, redness, itching, dryness, or peeling.

Safety notes advise caution regarding the potential for systemic salicylate toxicity (salicylism) when the product is used excessively or for prolonged periods over large areas of the skin. Restrictions are in place for individuals with certain pre-existing conditions, such as severe kidney disease, liver impairment, or poor blood circulation, where the risk of systemic absorption is increased.

Adverse Reaction Category Primary Safety Concern Regulatory Status
Population-Specific Risk Reye's Syndrome in children/teens with viral illness Contraindication/Warning
Hypersensitivity/Allergy Severe allergic reaction (Anaphylaxis) Serious Adverse Event
Local Skin Reactions Irritation, redness, burning Common/Frequent
Systemic Absorption Salicylism/Toxicity Use Limitation/Caution

Overdose and Emergency Response

Overdose and When to Seek Help

Salicylate toxicity (overdose) is a serious medical emergency. The risk for toxicity is generally considered to begin with an acute ingestion of a dose ge 150 mg/kg of aspirin equivalent. However, severe poisoning can occur with smaller doses, especially in children or with certain formulations like Oil of Wintergreen (methyl salicylate), where ingestion of less than 5 milliliters can be fatal to a small child.

Documented Manifestations and Symptoms

Early symptoms of salicylate toxicity, known as salicylism, may include tinnitus (ringing in the ears), nausea, vomiting, and hyperventilation. As toxicity progresses, more serious symptoms can develop, such as confusion, lethargy, fever (hyperthermia), and eventually, seizures or coma.

Chronic overdose, which can occur after days of higher-than-recommended dosing, may present with less specific symptoms like unexplained confusion or a change in mental status, particularly in older adults.

Emergency Action

Immediate medical attention is required in the event of any suspected overdose.

If an overdose is known or suspected, or if any of the above symptoms appear, you must get medical help or contact a Poison Control Center right away. Do not wait for symptoms to worsen. Due to the risk of severe metabolic and respiratory complications, all symptomatic patients require prompt emergency department evaluation.

Therapeutic Uses of Salic

What Salic Treats: Main Uses and Benefits

Salic is commonly used in dermatological practice to manage chronic inflammatory skin conditions that are characterized by significant thickening. This topical combination is generally relevant for conditions presenting with hyperkeratotic and dry corticosteroid-responsive dermatoses, including plaque psoriasis and certain forms of refractory eczema. It is applied in clinical settings that involve acute or disruptive symptom patterns, and may help make episodes easier to tolerate during periods of heightened symptoms.

The primary therapeutic benefit focuses on providing simultaneous symptomatic relief from two distinct patterns: the intense inflammation (redness and swelling) and the excessive scaling and crusting that forms thick, hardened plaques. The anti-inflammatory component is used for managing symptoms related to inflammatory states, and may assist with symptomatic relief that helps patients cope more steadily with difficult episodes. This combination is helpful in situations where symptoms create noticeable functional strain, ultimately easing the overall burden of distressing manifestations and assisting with maintaining functional stability for adults and adolescents.


Quick Fact: Relief for Inflammation and Scaling

Salic is commonly used to help manage symptoms related to inflammation, pruritus (itching), hyperkeratosis, and plaque formation.

Eligibility and Restrictions for Use

Who Can and Cannot Use Salic?

The eligibility profile for Salic (Betamethasone Dipropionate and Sodium Salicylate) is strictly defined by regulatory authorities based on documented contraindications and specific population restrictions.

Populations for Whom Use is Contraindicated

Use is prohibited for patients with a known hypersensitivity to Betamethasone, Salicylates, or any preparation ingredients. The medicine must not be used on skin lesions caused by viral infections (e.g., herpes simplex, chickenpox), or on untreated bacterial and fungal infections. It is also contraindicated for application on rosacea, acne vulgaris, and perioral dermatitis.

Age and Physiological Restrictions

Eligibility is limited by age: use in infants and children under 12 years of age is generally not recommended or formally contraindicated due to the significantly increased risk of systemic absorption and toxicity. For pregnancy and lactation, use is also generally not recommended unless the potential benefit outweighs the risk, with application to the breast area strictly prohibited while breastfeeding.

Conditional Eligibility

Use is restricted on large body surface areas or under occlusive dressings due to the potential for systemic absorption of the active components. Caution or restriction is also advised for patients with impaired renal function due to the potential for salicylate accumulation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Salic (Betamethasone Dipropionate/Sodium Salicylate) is determined by the potential for systemic absorption of its two active components, as documented in official regulatory sources.

Documented Interaction Patterns

Pharmacodynamic Additive Exposure Risk Co-administration with other corticosteroid-containing products is an officially documented interaction pattern. This results in a pharmacodynamic additive effect, leading to an increase in total systemic glucocorticoid exposure and the associated risks, such as Hypothalamic-Pituitary-Adrenal (HPA) axis suppression.

Systemic Salicylate Protein-Binding Potential When systemically absorbed, the salicylate component may engage in a protein-binding displacement interaction by competing with other highly protein-bound medicinal products for binding to plasma albumin. This interaction can formally modify the action of the co-administered medicine.

Interaction-Related Restrictions and Constraints

Official documents outline that conditions which augment systemic absorption are considered procedural interaction constraints. The use of occlusive dressings or application to large surface areas or for prolonged periods heightens the risk for all systemic interaction patterns.

Population-Specific Caution: Patients with liver failure are officially identified as a population at increased risk for systemic adverse effects due to potentially altered clearance of topical corticosteroids, increasing the potential severity of systemic interactions.

Mechanism of Action

How Salic Works

Enzyme Inhibition and Systemic Modulation

Salic acts primarily as an inhibitor of cyclooxygenase (COX) enzymes (COX-1 and COX-2) found intracellularly. By preventing these enzymes from engaging their substrate, the drug reduces the conversion of arachidonic acid into pro-inflammatory signaling mediators, specifically prostaglandins and thromboxanes. This mechanism modulates mediator systems associated with inflammation throughout the body. Furthermore, this action influences the central thermoregulatory system within the hypothalamus, leading to a resetting of the body's temperature set point.

Modulation of Keratinocyte Adhesion

When applied topically, a distinct action occurs on the skin's surface. Salic targets the protein structures (desmosomes) that promote adhesion between the outer layers of skin cells (keratinocytes or corneocytes). This interaction weakens the bonds that hold these surface cells tightly together. This cascade affects epidermal integrity, resulting in the enhanced separation of corneocytes and promotes desquamation of the stratum corneum by modifying cell adhesion.

Dosage and Administration Information

How Salic Is Used: Official Administration Guidelines

Salic (Betamethasone Dipropionate/Sodium Salicylate) is administered via the topical route for application solely to the skin and scalp. The medication is applied as a thin film covering the affected area, typically once or twice daily. Regulatory guidelines state that application should be limited in quantity, and the total amount used by adults must not exceed 60 grams per week.


Procedural and Contextual Constraints

The administration protocol mandates specific procedural conditions. The preparation must not be used on sensitive skin areas, including the face, groin, or axillae (armpits). Additionally, the treated area must not be covered with occlusive dressings or bandages, as this may affect absorption. For the lotion formulation, the product should be lightly massaged until it disappears into the skin.


Duration and Review Limits

Treatment duration requires strict adherence to labeled limits. For adults, the use of Salic should be reviewed after two weeks of continuous application. In the pediatric population (children), the treatment course is strictly limited to five days and the smallest necessary amount must be used to mitigate potential systemic exposure. Therapy is generally discontinued once the desired control over the skin condition is achieved.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Salic

The clinical evaluation for Salic (the fixed combination of a potent topical corticosteroid and a keratolytic agent) was studied in clinical trials for specific inflammatory skin conditions. The evidence base primarily consists of official regulatory summaries and findings from randomized controlled trials (RCTs), including specific designs like split-body studies, which are a common study type used for clinical evaluation, and other comparative studies. The research examined how symptoms evolved in study populations and was mostly applied in research contexts involving short-term or episodic symptom patterns.


Evidence for Use in Plaque Psoriasis

The largest body of research for Salic was studied for plaque psoriasis, including cases that involve skin thickening (hyperkeratosis). Researchers primarily conducted short-term RCTs, often using a split-body design. These studies involved adults with moderate to severe disease, including those with localized patches like scalp psoriasis.

The studies monitored several key factors, including investigator global evaluation scores and patient-reported outcomes describing perceived discomfort. Research highlights changes measured during the study period across three main symptom axes: scaling, erythema (redness), and pruritus (itching). Findings describe patterns where the combination was associated with different outcomes for scaling compared to the potent steroid used alone.


Comparison of the Combination Components

A significant portion of the evidence for Salic was observed in trials specifically designed to compare the two-ingredient product against its individual ingredients. These specialized studies were used in research exploring short-term symptom changes to determine the roles of the steroid and the keratolytic agent when used together.

The data show patterns related to the speed and magnitude of change in specific symptoms, particularly scaling and hyperkeratosis. For these specific outcomes, findings describe patterns where the combination product was frequently observed to track better measured changes than the steroid or the keratolytic agent applied by itself.


Key Limitations and Areas of Uncertainty

The available regulatory research for Salic is primarily based on short-term studies, reflecting that the follow-up durations were limited in the primary evaluation phases. As a result, the long-term effects are not fully established. There is limited information for long-term outcomes concerning the overall course of the disease or the durability of the observed effects.

The evidence highlights that comparative evidence is limited regarding how Salic compares directly against other topical treatments. Furthermore, data for certain groups remain insufficient. Specifically, subgroup findings are uncertain or lacking for specialized populations, such as children or older adults, where the condition may be managed differently.

Frequently Asked Questions (FAQ)

Common questions about Salic (FAQ)


Q: What is the official indication for Salic?

Official product information states that the medicine is indicated for the topical treatment of specific inflammatory, dry, and scaly skin disorders. These conditions must be responsive to corticosteroids, and examples include certain types of eczema and psoriasis.


Q: Can Salic be used for more than one medical condition?

Yes, the official indication for Salic covers a class of skin conditions, not just a single disease. Since it is a combination of an anti-inflammatory and a keratolytic agent, its use is intended for inflammatory, dry, and scaling disorders such as both eczema and psoriasis.


Q: Is Salic a pain reliever or a disease modifier?

Salic is classified in regulatory documents as a Topical anti-inflammatory preparation (a corticosteroid) and a keratolytic agent. Its therapeutic action is intended to address inflammation and scaling, which are key aspects of the condition.


Q: Is Salic available as a generic version?

Yes. The components of Salic are well-known active ingredients, and the combination product is widely available globally. The product is offered under multiple generic names and repackaged labels from various manufacturers.


Q: Is Salic a controlled substance?

No, according to regulatory schedules, the active components of Salic—Betamethasone Dipropionate and Sodium Salicylate—are not classified as controlled substances under the U.S. Drug Enforcement Administration (DEA) schedule.


Q: How long does it usually take for patients to feel the effects of Salic?

Clinical information suggests that a reduction in symptoms may be observed within three to four days of beginning treatment. However, the exact timing can depend on individual factors and the severity of the condition.


Q: Can the timing of the effect vary significantly between patients?

Official product information indicates that the speed at which the drug works depends on "individual patient factors." This suggests that the timing and magnitude of the therapeutic effect can indeed vary significantly between different patients.


Q: Why is Salic typically prescribed long-term?

Official regulatory documents generally advise against long-term continuous use of Salic. This caution is in place to minimize the potential for systemic side effects from the corticosteroid component. Regulatory guidelines indicate that continuous use is typically limited and require a review of treatment duration, such as after two weeks for adults.


Q: How long does Salic stay in the system after the last dose?

Official documents contain pharmacokinetic data that can offer some indication of the drug's presence in the body. For the salicylate component, pharmacokinetic data suggest it remains in the system for several hours, depending on the level of absorption.


Q: If Salic is stopped, how long until its effects wear off?

Official documents do not quantify how long the drug's effects take to wear off. However, the regulatory text highlights that stopping treatment, especially after prolonged use, may lead to a rapid return or worsening of symptoms, sometimes referred to as a rebound effect.


Q: Does Salic cause weight gain or weight loss?

Systemic absorption of the corticosteroid component can lead to adverse effects like adrenal gland problems or Cushing’s syndrome. These conditions, typically associated with long-term, high-dose use, can potentially result in either weight gain (Cushingoid features) or weight loss (adrenal issues).


Q: Is a mild headache a common reaction when starting Salic?

Headache is not listed among the most common local skin reactions. However, headache is listed as a potential, though rare, side effect that may be associated with systemic effects, such as high blood pressure or adrenal gland problems.


Q: How often do people experience gastrointestinal issues with Salic?

When the salicylate component is absorbed systemically, there are associated cautions regarding the potential for gastrointestinal issues. These can include mucosal damage and gastrointestinal bleeding, which is a key safety caution for the product.


Q: Is fatigue a common side effect of Salic?

Fatigue is not listed as a common local side effect of the topical application. However, extreme tiredness or fatigue is listed in regulatory sources as a potential side effect associated with serious systemic issues, such as adrenal gland problems or chronic salicylate poisoning.


Q: Does Salic have a known risk of liver damage?

Due to the potential for systemic absorption, official warnings relate the salicylate component to liver safety. The salicylate component is associated with the rare but serious condition Reye's syndrome, which includes liver damage and is contraindicated in children recovering from viral illness.


Q: What safety warnings are specifically highlighted in the Boxed Warning for Salic, if any?

While the official product label may not feature a formal 'Boxed Warning,' several safety warnings are prominently highlighted. These cautions primarily relate to the potential for the corticosteroid component to cause Hypothalamic-Pituitary-Adrenal (HPA) axis suppression with excessive use. Long-term use also increases the risk of cataracts and glaucoma.


Q: Is it safe to take Salic with common pain relievers like Ibuprofen or Tylenol?

Official drug information notes potential for interaction with certain common pain relievers, including Acetaminophen (Tylenol) or NSAIDs like Ibuprofen. Combining Salic with these products may lead to additive side effects and/or increased systemic risks due to the absorption of the salicylate component.


Q: Is it true that Salic can increase bleeding risk with certain medicines?

Official safety information notes a potential for increased risk of bleeding, especially when the salicylate component is systemically absorbed and combined with certain other medicines, such as anticoagulants.


Q: Does Salic interact with alcohol?

While there is no direct contraindication for topical use with alcohol, official safety information indicates that alcohol use is a factor that can increase the risk of GI bleeding when systemic absorption of salicylates occurs.


Q: Is it safe to take cold and flu medication while on Salic?

Official caution statements address cold and flu medications because these products may contain ingredients that can lead to increased systemic risks or toxicity when combined with Salic. This includes ingredients such as Acetaminophen, other salicylates, or NSAIDs.


Q: Does Salic affect the results of common lab tests?

Yes, high systemic absorption of the salicylate component can affect the results of several laboratory tests. These include tests for salicylate blood level, acid-base balance, and blood glucose levels.


Q: Does Salic cause drowsiness when combined with other sedating medications?

Official safety warnings do not explicitly list drowsiness as a primary side effect. However, the systemic effects of the medication can include side effects like dizziness, confusion, and trouble sleeping, which are related to central nervous system (CNS) function.


Q: What is the official safety classification for Salic during pregnancy?

The betamethasone component of Salic is typically assigned a US FDA pregnancy category C. This classification indicates that the medicine should only be used during pregnancy if the potential benefit to the mother justifies the potential risk to the fetus.


Q: Is Salic contraindicated for people with a history of heart disease?

Official documents advise caution for patients with a history of heart failure, hypertension (high blood pressure), or pre-existing fluid retention. This caution is due to potential effects associated with the systemic absorption of the NSAID/salicylate component.


Q: Can patients with diabetes or high blood pressure take Salic?

Official precautions note that patients with diabetes mellitus should be mindful that corticosteroids have the potential to raise blood glucose levels. Caution is also advised for patients with high blood pressure (hypertension) due to the systemic risk of fluid retention.

How should Salic be stored and disposed of?

How to Store and Dispose of Salic?

Storage and disposal instructions for Salic (Betamethasone Dipropionate/Salicylic Acid) are strictly defined by regulatory labeling to maintain product stability and safety.


Storage Requirements

Condition Regulatory Mandate
Temperature Store below 25°C or at controlled room temperature.
Handling Do not freeze and keep the container tightly closed.
Protection Keep away from fire, heat, and flame; protect from light.
Child Safety Must be kept out of the sight and reach of children.

Disposal

Expired or unused Salic must not be thrown away with household trash or poured into wastewater. To comply with local regulations, return the product to a pharmacy or designated collection point for safe pharmaceutical waste handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Salic found in:

A-Z Index: